Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bentley Biomedical Consulting is a private U.S. regulatory consulting firm serving the medical device, pharmaceutical, and broader healthcare sectors. The company focuses on helping clients obtain regulatory approvals and market access in the United States and internationally, with services including FDA medical device submissions, 505(b)(2) drug approval support, ANDA-related work, and combination product regulatory strategy. It appears to operate primarily as a specialized advisory business rather than a drug developer with an internal therapeutic pipeline. Publicly available information indicates the firm was founded in 2006, is based in Laguna Niguel, California, and is led by Shepard G. Bentley. For a biotech analyst, the company is best understood as a niche regulatory affairs consultancy supporting product development and commercialization rather than a therapeutic asset company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bentley Biomedical Consulting.